戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 u (reported in the ExAC database in a single heterozygote).
2 otes) and 25 family B members (10 men and 15 heterozygotes).
3 knockout mice than in controls (wild-type or heterozygotes).
4 elevant to cancer in FANC-mutation carriers (heterozygotes).
5 t the underlying T1 was a nonchimeric double heterozygote.
6 ss-of-function, but present in either single heterozygote.
7 into greater than half of the offspring of a heterozygote.
8  in yeast) that do not inherit the gene from heterozygotes.
9 ng slightly biased toward the risk allele in heterozygotes.
10 mozygotes and markedly increased VTE risk in heterozygotes.
11  of ectopic filopodia is increased in Sema2a heterozygotes.
12 rosophila with 88-95% transmission by female heterozygotes.
13 ies this improves the resolution of compound heterozygotes.
14 ed with protection against severe malaria in heterozygotes.
15 ically depleted for meiotic recombination in heterozygotes.
16 explaining why the former is dominant in A/C heterozygotes.
17 ed in homozygotes, whereas it is buffered in heterozygotes.
18 nd higher levels of HDL cholesterol than did heterozygotes.
19  mutant alleles are outcrossed to produce F1 heterozygotes.
20  identified with POLG2-related disorders are heterozygotes.
21 ants in genes likely to cause a phenotype in heterozygotes.
22 lar to Irf6 hypomorphic mutants and Arhgap29 heterozygotes.
23  cardiac lymphatic abnormalities in compound heterozygotes.
24  have identified arrhythmic phenotypes among heterozygotes.
25  generating viable mice in crosses of double heterozygotes.
26 e pattern of selection against interspecific heterozygotes.
27 eption, even in apparently clinically silent heterozygotes.
28 +/- 5% of the total PrP from the G(96)/S(96) heterozygotes.
29 zygotes, intermediate deficits being seen in heterozygotes.
30 ygotes had lower enzymatic activity than GBA heterozygotes (0.85 micromol/l/h versus 7.88 micromol/l/
31  combined P = 3.4 x 10(-7); relative risk to heterozygote: 1.6, 95% CI: 1.4-2.0) and between LSLs and
32  combined P = 6.3 x 10(-7); relative risk to heterozygote: 1.6, 95% CI: 1.4-2.0).
33 omozygotes and compound heterozygotes and 81 heterozygotes, 17.0% versus 17 heterozygotes, 6.7%, P <
34 inically insignificant except in G6PD female heterozygotes, 2 of whom had hematocrit reductions to <2
35  combined P = 4.0 x 10(-9); relative risk to heterozygote: 2.6, 95% CI: 1.9-3.7).
36 ygotes and 81 heterozygotes, 17.0% versus 17 heterozygotes, 6.7%, P < 0.001).
37 ble plasma levels was observed in Hhip (+/-) heterozygotes; a strong gene-by-smoking association was
38 ests for tests of variants with less than 20 heterozygotes across the sample, regardless of the total
39 selection and can cause a balanced state via heterozygote advantage (the staggered phase), and (iii)
40                                              Heterozygote advantage and negative frequency-dependent
41                                     Apparent heterozygote advantage at the neutral locus is, however,
42                                         With heterozygote advantage at the selected locus, loss of va
43 for the observed high inbreeding depression, heterozygote advantage could not be excluded.
44 susceptible (OR=3.26; P=0.006), suggesting a heterozygote advantage effect.
45                                  Examples of heterozygote advantage in humans are scarce and limited
46 enetic drift, migration, constant selection, heterozygote advantage or negative frequency-dependent s
47 mentals (pseudo-overdominance) and intrinsic heterozygote advantage was examined and compared with th
48 ognition, overdominance (also referred to as heterozygote advantage) has been suggested as the main d
49 aintenance of polymorphism by overdominance (heterozygote advantage) is a fundamental concept in evol
50                                    We find a heterozygote advantage, resulting in higher fitness for
51 as negative frequency-dependent selection or heterozygote advantage.
52 sity and healthy aging could be explained by heterozygote advantage.
53 t AID mutations (AD-AID), asymptomatic AICDA heterozygotes (AID+/-), and patients with uracil N-glyco
54                         Surprisingly, asy1/+ heterozygotes also remodel crossovers toward subtelomeri
55 ined 437 SNPs in the 3'UTR with at least one heterozygote among the subjects studied.
56 ase cohort, we confirmed the effects of PI Z heterozygote and compound heterozygote genotypes.
57 e genotypes at Sema3d locus, and Sema3d null heterozygote and homozygote mice had normal intestinal i
58 6P9a-RR) developed significantly slower than heterozygote and homozygote susceptible mosquitoes (chi(
59 enotype that is more severe than each single heterozygote and indistinguishable from that of the cond
60 ening (heterozygote, homozygote, or compound heterozygote and mtDNA homoplasmy or heteroplasmy), amon
61        Survival rates of Ret wild-type, null heterozygote and null homozygote mice at E12.5, birth an
62 ng 36 CPVT probands (24 homozygotes/compound heterozygotes and 12 heterozygotes) and 76 family member
63 pared clinical information from 111 compound heterozygotes and 131 individuals with homozygous expans
64                           We identified 1661 heterozygotes and 17 homozygotes for the E40K variant an
65   18/26 (69.2%) classified as mild were beta heterozygotes and 17/18 (94.4%) had excess alpha globin
66 onfidence interval [CI], 1.70 to 2.56) among heterozygotes and 5.70 (95% CI, 4.66 to 6.97) among homo
67 /12 (91.6%) classified as moderate were beta heterozygotes and 8/11 (72.2%) had excess alpha globin g
68  or variants (seven homozygotes and compound heterozygotes and 81 heterozygotes, 17.0% versus 17 hete
69 : The role of PI (protease inhibitor) type Z heterozygotes and additional rare variant genotypes in t
70 cores were observed between patients with GD/heterozygotes and controls (all P < .05).
71 nt with a model of balanced selection, where heterozygotes and homozygotes have higher and lower repr
72 e demonstrate that disease manifests in both heterozygotes and homozygotes, indicating a common colla
73                                      In both heterozygotes and homozygotes, levels of calreticulin pr
74 pheral neuropathy and multisystem disease in heterozygotes and homozygotes, respectively.
75 lesterol and low HDL-cholesterol in compound heterozygotes and homozygous individuals, decrease rever
76 re we show that mutation rates are higher in heterozygotes and in proximity to crossover events.
77                        On average, c.1141G>C heterozygotes and individuals homozygous for rs532464664
78          We found that both human APOC3 A43T heterozygotes and mice expressing human APOC3 A43T displ
79 tant mice exhibit earlier seizure onset than heterozygotes and more rapid progression to death.
80  reflect the strength of selection acting on heterozygotes and not dominance or haploinsufficiency.
81 1 p.G411S carriers compared to PINK1 p.Q456X heterozygotes and PINK1 wild-type controls under endogen
82  random sampling of homologous base pairs in heterozygotes and sequencing or alignment errors.
83 of-function variants that are deleterious as heterozygotes and those causing disease only in the homo
84 plasma, urine, and lung tissue of Hhip (+/-) heterozygotes and wild type (Hhip (+/+)) C57/BL6 mice ex
85 ted ALV-J-resistant, in contrast to DeltaW38 heterozygotes and wild-type birds, which were ALV-J-susc
86 s in GJB2 or SLC26A4 (homozygote or compound heterozygote) and 10 of those infants passed newborn hea
87 utations in 16 family A members (8 men and 8 heterozygotes) and 25 family B members (10 men and 15 he
88 24 homozygotes/compound heterozygotes and 12 heterozygotes) and 76 family members possessing at least
89 from NPC1 (untreated and miglustat treated), heterozygote, and healthy control subjects.
90 rols and genotyped for Hp, hemoglobin (Hb) S heterozygotes, and alpha(+)thalassemia.
91 provide a better way of identifying superior heterozygotes, and quantifying the advantages of genetic
92 included individuals with complete (compound heterozygote) ANGPTL3 deficiency, a population based-stu
93 pulation based-study of humans with partial (heterozygote) ANGPTL3 deficiency, and biomarker levels i
94 variants correctly, often mistakenly calling heterozygotes as reference homozygotes.
95 result in an apparent selective advantage to heterozygotes at the neutral locus (associative overdomi
96 a-related phenotypes were observed in double heterozygotes, but all three double homozygous mutant li
97 tch-that developed postnatally in wild-types/heterozygotes, but not in knockouts.
98  We find that this variant reduces height in heterozygotes by an average of 4.2 cm (-0.64 s.d.).
99 362A>T [p.His121Leu]) and another a compound heterozygote (c.79T>C [p.Tyr27His] and c.217_225del [p.V
100 ed in WT, ~40% of PT synapses tested in Q175 heterozygotes can be classified as dysfunctional.
101  controls (0.225 mmol trolox equivalent) and heterozygote carriers (0.181 mmol trolox equivalent), an
102 s (150/314) of valine at position 11, 61% of heterozygote carriers (130/213), and 74% of homozygote c
103                                          The heterozygote carriers are all female.
104              Affected NPC1 patients and NPC1 heterozygote carriers had reduced NK-cell numbers in the
105  analyzing 8,711 individuals, we showed that heterozygote carriers of this low-frequency variant have
106 ce of the pathogenic mutants suggesting that heterozygote carriers presumably do not show symptoms re
107 ients] with moderate or good EULAR response; heterozygote carriers: 81% [698/866]; and homozygote car
108 P and higher heart rate than noncarriers and heterozygote carriers; they also had significantly highe
109                                              Heterozygotes carry the genetic information for two diff
110                        Furthermore, compound heterozygotes carrying the Bmp7(R-G) allele together wit
111 cs analyses revealed the bull was a compound heterozygote, carrying one naturally occurring P(C) Celt
112                            Relative to CASQ2 heterozygotes, CASQ2 homozygote/compound heterozygote ge
113                                      B15/B21 heterozygote cells show much greater expression of B15 c
114 ssion of an alternative isoform of HBP1 in a heterozygote chondrosarcoma cell line, in a CRISPR-edite
115         Among CASQ2 homozygotes and compound heterozygotes, clinical penetrance was 97.1% and 26 of 3
116   Glucocerebrosidase activity was reduced in heterozygotes compared to non-carriers when each mutatio
117  of the CO network showed higher activity in heterozygotes compared with both types of homozygotes du
118 nt scores were lower in patients with GD and heterozygotes compared with controls, but they did not d
119 sex-adjusted hazard ratio for CHEK2*1100delC heterozygotes compared with noncarriers was 2.08 (95% CI
120                           For CHEK2*1100delC heterozygotes compared with noncarriers, the age- and se
121 A1.Measurements and Main Results: White PI Z heterozygotes confirmed by sequencing (MZ; n = 74) had l
122 e more pronounced in homozygous mice than in heterozygotes, consistent with the earlier age of seizur
123            There is increasing evidence that heterozygotes containing genetically divergent alleles a
124         The severity of myofibril defects in heterozygotes correlated with the level of flight impair
125 sed embryonic mortality compared with single heterozygote crosses.
126 ion, we detected 25 RAD loci showing extreme heterozygote deficiency in females but which were in Har
127     Additionally, doc2a+/- fam57ba+/- double heterozygotes demonstrate the increased body length and
128  p.R114W has reduced penetrance; only 54% of heterozygotes developed diabetes by age 30 years compare
129                         Homozygotes, but not heterozygotes, developed Parkinson signs in the middle a
130                                      p.R114W heterozygotes did not have the increased birth weight of
131               Single doc2a+/- and fam57ba+/- heterozygotes do not show a body size increase; however,
132  of APOE4 - 20 APOE4 homozygotes (E4/E4), 20 heterozygotes (E3/E4) and 20 non-carriers (E3/E3) - to d
133       The mortality of the FGF8/Fbln1 double heterozygote embryos occurred between 14.5 and 16.5 days
134  and Cofilin genetically interact, as double heterozygotes exhibit a reduction in the number of nurse
135 nical nuclear Notch pathway inhibitor, and H heterozygotes exhibit bristle cell fate phenotypes refle
136 nd 122, are lethal when homozygous and adult heterozygotes exhibit dominant neural dysfunction.
137  are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA an
138 int patterns of twitching; again, wild-types/heterozygotes exhibited developmental changes in twitch
139                                  In compound heterozygotes, expression of partially functional mutant
140 ols (2.66 units/mg protein) and samples from heterozygote female carriers (1.91 units/mg protein), pa
141 ts with cALD or adrenomyeloneuropathy (AMN), heterozygote female carriers, and healthy controls and,
142 ospectively collected from healthy controls, heterozygote female carriers, and patients with AMN or c
143 patients who received a diagnosis of ALD and heterozygote female carriers, both of which groups were
144 bility is not restored in homozygotes, young heterozygotes fly well.
145 e fetus with renal microcysts was a compound heterozygote for p.Glu643Ala and p.Asn800Lys, and one ch
146 ith complete PCSK9 deficiency (each compound heterozygote for PCSK9 p.Y142X and p.C679X) were identif
147                Two individuals were compound heterozygotes for a previously reported point mutation i
148   Haplotype analysis of 4 homozygotes and 11 heterozygotes for c.5461-10T-->C and sequence analysis o
149 howed that VEC-specific conditional compound heterozygotes for Crim1 and Vegfa exhibit a phenotype th
150                               Nineteen white heterozygotes for five non-S/Z coding variants associate
151 rothrombin G20210A; 8.2% (5.5%) for compound heterozygotes for FVL and prothrombin G20210A; 9.0% (6.1
152 l in revealing predisposing abnormalities in heterozygotes for GBA1 mutations and demonstrating the d
153  cblC deficiency were homozygous or compound heterozygotes for mutations in the methylmalonic aciduri
154 gs of Moroccan Jewish ancestry were compound heterozygotes for p.A33D and p.P134R, and 6 patients bel
155 ulomegaly and renal microcysts were compound heterozygotes for p.Asn800Lys and p.Trp759Ter, one fetus
156 computed tomography-confirmed emphysema were heterozygotes for the Ala455Thr mutation.
157 were markedly reduced in homozygotes but not heterozygotes for the Pro90Ser CD36 mutation, whereas wh
158 is analysis revealed profound differences in heterozygote frequencies among populations (allele frequ
159 sease is highly prevalent in Ashkenazi Jews (heterozygote frequency, approximately 9%), whereas it is
160  polymorphism balanced through protection of heterozygotes from malaria mortality.
161                                We found that heterozygote GALC mutant mice have reduced myelin debris
162 nces occur in Ednra(+/-); Plxna4(+/-) double heterozygotes, genetically confirming functional interac
163                  Human participants with the heterozygote genotype also had subtle alterations in the
164 SQ2 heterozygotes, CASQ2 homozygote/compound heterozygote genotype status in probands was associated
165 pants in the 3C-Dijon cohort (0.4%) carrying heterozygote genotypes at known pathogenic variants for
166 ern alleles is consistent with the excess of heterozygote genotypes at the supergene locus controllin
167 he effects of PI Z heterozygote and compound heterozygote genotypes.
168    We also considered ambiguity in polyploid heterozygote genotyping and developed a weighting method
169 is in relation to G6PD genotype and that the heterozygote groups were small.
170  fewer FDL lesions were found in both double heterozygote groups, indicating a partial restoration of
171  the expected PKA-II decrease in both double heterozygote groups.
172 1) homozygous expansions, and three compound heterozygote groups; (2) null (no frataxin produced); (3
173 a significant genotype main effect (wildtype>heterozygote&gt;null mutant).
174                        Family A and family B heterozygotes had less severe or no clinical manifestati
175 ersus 7.88 micromol/l/h, P < 0.001), and GBA heterozygotes had lower enzymatic activity than GBA and
176                     GBA homozygotes/compound heterozygotes had lower enzymatic activity than GBA hete
177                                        C213Y heterozygotes had significantly decreased overall Prph2
178                   The null group of compound heterozygotes had significantly earlier age of onset and
179                                 In contrast, heterozygotes had their fertility life table parameters
180  and sinus-node dysfunction, whereas related heterozygotes harboring missense variants presented with
181                                    Human AIP heterozygotes have episodic acute neurovisceral attacks
182                                         RFX6 heterozygotes have reduced penetrance of diabetes compar
183 e loss; however, SE(del)/knockout (KO) trans heterozygotes have thin optic nerves.
184 ng both the rare and common TomLoxC alleles (heterozygotes) have higher TomLoxC expression than those
185 n (>14 years): 4 homozygotes and 17 compound heterozygotes (hereafter referred to as carriers) and 23
186 position grafts, using wild type (WT) or A20 heterozygote (HET) C57BL/6 (H-2) donors and BALB/c (H-2)
187 4.508%) were positive for genetic screening (heterozygote, homozygote, or compound heterozygote and m
188 nt (e756del), we compared phenotypes between heterozygotes, homozygotes, and wildtypes.
189                                    Recently, heterozygote human FLI1 mutations have been ascribed to
190                                Placing these heterozygotes in higher Nutlin-3a doses selected clones
191 el pathogenic MTHFR mutations, 2 as compound heterozygotes in one family and 1 as a homozygous mutati
192 duals in the human population are functional heterozygotes in that D17Z1 is the active centromere on
193 p between 2 and 6 months of age in Q175 male heterozygotes, indicating early effects of the HD mutati
194 der decrease in neurogenesis was observed in heterozygotes, indicating SOX2 levels are important.
195 dings suggest that altered P2X7R function in heterozygote individuals disturbs sleep and might increa
196  efficient, with 91% of the progeny of drive heterozygotes inheriting the drive allele and with no fu
197 g mutations; engineering these mutations, as heterozygotes, into the ancestral diploid strain caused
198 ck-in (KI) mice containing the A8V mutation (heterozygote=KI-TnC-A8V(+/-); homozygote=KI-TnC-A8V(+/+)
199  albicans yeast and hyphal kinesin-5 (Kip1p) heterozygotes (KIP1/kip1), we found that mutant spindles
200 ion did not have a gross phenotype, compound heterozygote knockout (KO) and KI mP215L mice were gener
201 icrobiota in ovariectomized ob/ob (obese) or heterozygote (lean) mice fed high-fat diet (HFD) that re
202 cles compared to the titers in wild-type and heterozygote littermates.
203                               Interestingly, heterozygote males were also more competitive than homoz
204                                          Kdr heterozygote males were more likely to mate than homozyg
205 partially recessive mutations or in favor of heterozygotes, may result in an apparent selective advan
206 e, 0.93; mean follow-up, 2.93; P < .001) and heterozygotes (mean baseline, 0.10; mean follow-up, 2.30
207 e, 4.29; mean follow-up, 7.82; P < .001) and heterozygotes (mean baseline, 1.97; mean follow-up, 4.50
208                                        Armc5 heterozygote mice (Armc5+/-) developed normally but at t
209                              We used elastin heterozygote mice (Eln(+/-) ) as a model of increased la
210    In vivo, inadequate A20 expression in A20 heterozygote mice aggravated intimal hyperplasia followi
211                                     Compound heterozygote mice already have reduced numbers of myelin
212 nockout mice and found that when EdnrB (-/+) heterozygote mice are treated with lower levels of oxyge
213  old age, we now report that Nmnat2 compound heterozygote mice present with early and age-dependent p
214 e cell cycle in mammary epithelial cells and heterozygote mice spontaneously develop mammary tumors.
215                         By 30 d, Tmc1 pD569N heterozygote mice were profoundly deaf, and there was su
216                     In cardiac-specific Bin1 heterozygote mice, isoproterenol fails to concentrate BI
217 nce tests, with intermediate effects in Nat1 heterozygote mice.
218         In the present study, we report on a heterozygote mutation in ELOVL4 in affected individuals
219 mutations and Parkinson's disease (PD), with heterozygote mutations in GBA1 considered the commonest
220 fied an FH patient presenting novel compound heterozygote mutations R410S and G592E of the LDL recept
221 (+/-), PlexinA2(+/-) neurons, but not single-heterozygote neurons, are rescued from Nogo-A inhibition
222 arly postnatal to adult ages in female Mecp2 heterozygotes of the conventional Bird line (Mecp2tm1.1b
223 function alleles of dysb, Blos1, or compound heterozygotes of these alleles impaired neurotransmitter
224 ids of the selected and susceptible strains (heterozygotes) on DAS-444O6-6 x DAS-81419-2 soybean with
225 (GNPAT) polymorphism p.D519G (rs11558492; 15 heterozygotes, one homozygote).
226 sed virus-induced mortality compared to Asyn heterozygote or homozygote control mice.
227 s, whereas healthy family members are either heterozygote or homozygote for the reference allele.
228 d Wnt (MMTV-Wnt) transgenic mice to the SOD1 heterozygote or knockout mice.
229 cess alpha globin genes in beta thalassaemia heterozygotes or alpha globin gene deletions in beta tha
230 n who had the lowest-risk genotypes (DR4-DQ8 heterozygotes or homozygotes).
231 405, whereas 13 healthy siblings were either heterozygotes or lacked the mutant allele.
232 alization at 30 days to 1 year compared with heterozygotes or those homozygous for the non-P-gp-lower
233 e mosquitoes (CYP6P9a-SS) lay more eggs than heterozygote (OR = 2.04: P = 0.01) and homozygote resist
234 with Plasmodium infection in Obout than both heterozygote (OR = 2.5; P = 0.012) and homozygote suscep
235 hitecture for a simulated gene is a compound heterozygote, our method is better able to capture the s
236 .Cys282Tyr homozygotes and 2.3% for compound heterozygotes (p < 0.001).
237 .Cys282Tyr homozygotes and 3.5% for compound heterozygotes (p < 0.001); in females, it was 14.0% for
238 MR)-deficient colorectal cancer cells formed heterozygote (p53 wild-type/mutant) colonies when cultur
239 nts appeared to be shorter than that seen in heterozygote patients.
240                                 Furthermore, heterozygotes performed more accurately in behavioral ta
241  been devoted to the mechanisms underpinning heterozygote phenotype and its consequences for allele f
242 pe paternal allele expression attenuates the heterozygote phenotype.
243 -GWAS for an obligate outcrossing and highly heterozygote plant genus suggests that this approach may
244                                              Heterozygote plasma samples displayed also increases in
245 h, and the absence of any overt phenotype in heterozygotes provides important in vivo precedent for t
246                                   Similarly, heterozygote RDL(R)/RDL(S) were also more likely to mate
247                                              Heterozygotes remain seizure free for another month.
248 Hh-signaling through Smo co-mutation in Tbx5 heterozygotes rescued the limb defects, thus placing Tbx
249      Igf2r(I1565A/+p) maternal transmission (heterozygote), resulted in placental and embryonic over-
250         Reduced levels of TCF7, found in the heterozygote, resulted in a greater potential for Treg p
251  a gene dose-dependent manner when comparing heterozygote RMRP carriers with patients with CHH.
252 in autoantigen-binding repertoires between a heterozygote's two expressed HLA variants might result i
253                                              Heterozygotes shared similar phenotypic features includi
254 llelic interaction) at this locus, where the heterozygotes show higher activity in the cingulo-opercu
255 demonstrated that doc2a+/- fam57ba+/- double heterozygotes show hyperactivity and increased seizure s
256                                 Both sets of heterozygotes show the presence of both polymorphisms in
257                 The dgk2-1/+ dgk4-1/+ double heterozygote showed defective pollen tube growth and see
258 e-trap allele, Specc1lcGT/DeltaC510 compound heterozygotes showed a palate elevation delay with incom
259                   By contrast, PINK1 p.G411S heterozygotes showed no decrease of PINK1 protein levels
260     In contrast, hearts from homozygotes and heterozygotes showed normal morphology, myofibrillar arr
261               While cells from PINK1 p.Q456X heterozygotes showed reduced levels of PINK1 protein and
262 t MS of a rare genetic variant of P2RX7 with heterozygotes showing near absent proinflammatory 'pore'
263 We generated Zcchc8-null mice and found that heterozygotes, similar to human mutation carriers, had T
264                            We found that the heterozygote SM22alpha-Cre:SCAP(flox/+):ApoE(-/-) mice f
265 nd substantial homozygosity underlying fixed heterozygote SSR genotypes, which in turn reflect a self
266 , we confirm that Sls-GFP can be used in the heterozygote state without an obvious phenotype in IFM a
267 otes or the loop-tail phenotype in Lp mutant heterozygotes, suggesting that mice with these mutant al
268 ident in primary cultures of Nmnat2 compound heterozygote superior cervical ganglion neurons.
269 arian Vizslas revealed the presence of three heterozygotes, supporting the presence of carriers in th
270 actional haematocrit reduction >25%) in G6PD heterozygotes taking the higher (7 d) primaquine dose (9
271                                          Two heterozygotes taking the higher (7 d) primaquine dose re
272 maquine dose (9/17 [53%]) compared with G6PD heterozygotes taking the standard high (14 d) dose (2/16
273 proximately 3.5-fold higher mutation rate in heterozygotes than in homozygotes, with mutations occurr
274 n of vitamin status based on construction of heterozygotes that combine strong and hypomorphic mutant
275                     Even when expressed as a heterozygote, the Nan-EKLF protein accomplishes this by
276                                      In Pkd2 heterozygotes, the 50% PC2 reduction resulted in a noneq
277                             Importantly, for heterozygotes, the apoE4/apoE3 isoform ratio was increas
278                                           In heterozygotes, the mean fractional haematocrit reduction
279                                  In mtrm/(+) heterozygotes, there is a low level of sister centromere
280   We intercrossed Ret and Sema3d double null heterozygotes to generate mice with the nine possible ge
281  generated Arid1b-knockout mice and examined heterozygotes to model human patients.
282 ch selection operates is a duplicate/singlet heterozygote; to the best of our knowledge, this has not
283 , cardiac disease is reduced and survival of heterozygote Tsc2(S1365A) knock-in mice subjected to the
284 antly, vestibular function remains intact in heterozygotes up to 10 months, the latest time point tes
285 protein expression in tumours from nine G84E heterozygote variant and 13 wild-type carriers.
286 S2A rs1060826 versus homozygous wild-type or heterozygotes, we estimate an adjusted odds ratio (OR) o
287  reduced in a group of clinically unaffected heterozygotes, we propose that increasing LDL receptor-m
288 he results from the patients with GD and the heterozygotes were combined, a significant deterioration
289 .271dupA (p.R91KfsX14) patients and compound heterozygotes were noted.
290  lymphatic phenotype in Tbx1-Vegfr3 compound heterozygotes were regulated independently by the two ge
291  (odds ratio 1.88, P = 0.005) compared to AG heterozygotes whereas the AA homozygotes trended towards
292 n A315T TDP-43 protein were 300% elevated in heterozygotes, whereas the endogenous mouse Tdp-43 was d
293 duced diffusion capacity was observed in all heterozygotes with a history of smoking.
294 r this mutation and 2 siblings were compound heterozygotes with a splice site mutation c.1220 + 1G>C
295 ated poor growth and larval lethality, while heterozygotes with frameshift alleles survived to adulth
296 tabolomics associations identified 61 (5.1%) heterozygotes with phenotype manifestations affecting se
297 100% of homozygotes versus 37.5% of compound heterozygotes with transferrin saturation > 50%; p = 0.0
298  coding for HFE p.Cys282Tyr and 397 compound heterozygotes with variants resulting in p.[His63Asp];[C
299       Likewise, supplementation of K153Delta heterozygotes with WT-Prph2 results in structural but no
300                     PI Z-containing compound heterozygotes (ZS/ZV(R); n = 7) had lower FEV(1)/FVC (P

 
Page Top